These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14585219)

  • 1. The theta-defensin, retrocyclin, inhibits HIV-1 entry.
    Münk C; Wei G; Yang OO; Waring AJ; Wang W; Hong T; Lehrer RI; Landau NR; Cole AM
    AIDS Res Hum Retroviruses; 2003 Oct; 19(10):875-81. PubMed ID: 14585219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.
    Owen SM; Rudolph DL; Wang W; Cole AM; Waring AJ; Lal RB; Lehrer RI
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1157-65. PubMed ID: 15588337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrocyclin, an antiretroviral theta-defensin, is a lectin.
    Wang W; Cole AM; Hong T; Waring AJ; Lehrer RI
    J Immunol; 2003 May; 170(9):4708-16. PubMed ID: 12707350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation.
    Gallo SA; Wang W; Rawat SS; Jung G; Waring AJ; Cole AM; Lu H; Yan X; Daly NL; Craik DJ; Jiang S; Lehrer RI; Blumenthal R
    J Biol Chem; 2006 Jul; 281(27):18787-92. PubMed ID: 16648135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A theta-defensin composed exclusively of D-amino acids is active against HIV-1.
    Owen SM; Rudolph D; Wang W; Cole AM; Sherman MA; Waring AJ; Lehrer RI; Lal RB
    J Pept Res; 2004 Jun; 63(6):469-76. PubMed ID: 15175019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry.
    Yasin B; Wang W; Pang M; Cheshenko N; Hong T; Waring AJ; Herold BC; Wagar EA; Lehrer RI
    J Virol; 2004 May; 78(10):5147-56. PubMed ID: 15113897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin.
    Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
    Biochemistry; 2007 Sep; 46(35):9920-8. PubMed ID: 17685559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 adapts to a retrocyclin with cationic amino acid substitutions that reduce fusion efficiency of gp41.
    Cole AL; Yang OO; Warren AD; Waring AJ; Lehrer RI; Cole AM
    J Immunol; 2006 Jun; 176(11):6900-5. PubMed ID: 16709850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. theta-Defensin pseudogenes in HIV-1-exposed, persistently seronegative female sex-workers from Thailand.
    Yang C; Boone L; Nguyen TX; Rudolph D; Limpakarnjanarat K; Mastro TD; Tappero J; Cole AM; Lal RB
    Infect Genet Evol; 2005 Jan; 5(1):11-5. PubMed ID: 15567134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.
    Cole AM; Hong T; Boo LM; Nguyen T; Zhao C; Bristol G; Zack JA; Waring AJ; Yang OO; Lehrer RI
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1813-8. PubMed ID: 11854483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.
    Alfano M; Pushkarsky T; Poli G; Bukrinsky M
    J Virol; 2000 Sep; 74(18):8767-70. PubMed ID: 10954581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of alpha- and theta-defensins against primary isolates of HIV-1.
    Wang W; Owen SM; Rudolph DL; Cole AM; Hong T; Waring AJ; Lal RB; Lehrer RI
    J Immunol; 2004 Jul; 173(1):515-20. PubMed ID: 15210812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.
    Szabó J; Cervenák L; Tóth FD; Prohászka Z; Horváth L; Kerekes K; Beck Z; Bácsi A; Erdei A; Peerschke EI; Füst G; Ghebrehiwet B
    Clin Immunol; 2001 May; 99(2):222-31. PubMed ID: 11318594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrocyclin-2: a potent anti-HIV theta-defensin that forms a cyclic cystine ladder structural motif.
    Daly NL; Chen YK; Rosengren KJ; Marx UC; Phillips ML; Waring AJ; Wang W; Lehrer RI; Craik DJ
    Adv Exp Med Biol; 2009; 611():577-8. PubMed ID: 19400321
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.